Results 31 to 40 of about 243,754 (245)
Idiopathic membranous nephropathy (IMN) is a pathologically defined disorder of the glomerulus, primarily responsible for nephrotic syndromes (NS) in nondiabetic adults. The underlying molecular mechanisms are still not completely clarified.
Paolo Previtali +11 more
semanticscholar +1 more source
Background: Idiopathic membranous nephropathy (IMN) is the most common form of primary nephrotic syndrome in adults. Antibodies against the M-type phospholipase A2 receptor (PLA2R-ab) are considered as diagnostic biomarkers of IMN.
Jialing Zhang +3 more
semanticscholar +1 more source
Objective To investigate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy (IMN). Methods A total of 77 patients with IMN diagnosed in both our hospital and other hospitals were included in this study; the patients were ...
Ping-bo Chen +7 more
semanticscholar +1 more source
Update on New Antigens in the Pathogenesis of Membranous Nephropathy [PDF]
Previously, membranous nephropathies were divided into primary and secondary categories when the exact mechanism or pathogenetic factor were unknown. Approximately 70% accounted for primary membranous nephropathies.
Aris Tsalouchos, Maurizio Salvadori
core +1 more source
Aim Idiopathic membranous nephropathy (IMN) is a common type of nephrotic syndrome, and is associated with acute kidney injury (AKI). We investigated the association of multiple variables with AKI in patients with IMN.
Zhen-Zhou Li +11 more
semanticscholar +1 more source
Background To investigate the clinical and kidney pathological features and prognosis of idiopathic membranous nephropathy (IMN) with kidney tubulointerstitial damage (TID).
Mengyao Sun +6 more
semanticscholar +1 more source
Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study. [PDF]
New therapeutic agents are warranted in idiopathic membranous nephropathy. Synthetic ACTH may be advantageous with reported remission rates up to 85% and few side effects.
Anne-Els van de Logt +5 more
doaj +1 more source
Serum anti-phospholipase A2 receptor (anti-PLA2R) antibody is used for the noninvasive diagnosis of idiopathic membranous nephropathy (IMN). However, the cutoff value of anti-PLA2R antibodies in IMN patients is debatable.
Hongxia Guo +5 more
semanticscholar +1 more source
Background Common subtypes seen in Chinese patients with membranous nephropathy (MN) include idiopathic membranous nephropathy (IMN) and hepatitis B virus-related membranous nephropathy (HBV-MN). However, the morphologic differences are not visible under
Tianqi Tu +6 more
doaj +1 more source
Rituximab (RTX) and cyclophosphamide (CYC) based treatments are both recommended as first-line therapies in idiopathic membranous nephropathy (IMN) by KDIGO 2021 guideline. However, the efficacy of RTX vs.
Cheng Xue +10 more
semanticscholar +1 more source

